Ratings Kemira Oyj London S.E.

Equities

0MGG

FI0009004824

Real-time Estimate Tradegate Other stock markets 10:27:47 2024-06-27 am EDT			5-day change	1st Jan Change
23.26 ^EUR	+2.47%		-2.09%	+36.70%

Jun. 14	Fernanda Lopes Larsen to Leave the Board of Directors of Kemira Oyj, Effective as of July 31, 2024	CI
Jun. 10	Europe's STOXX 600 falls as French stocks roiled by political uncertainty	RE

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the past twelve months, EPS forecast has been revised upwards.
Over the past four months, analysts' average price target has been revised upwards significantly.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
KEMIRA OYJ	+36.70%	3.76B	-
SHIN-ETSU CHEMICAL CO., LTD.	+4.77%	76.9B	B
BASF SE	-6.58%	43.09B	A-
DUPONT DE NEMOURS, INC.	+3.96%	33.46B	C
PIDILITE INDUSTRIES LIMITED	+15.79%	19.32B	B
EASTMAN CHEMICAL COMPANY	+9.15%	11.55B	A-
BRENNTAG SE	-23.24%	9.88B	B
SYENSQO SA/NV	-9.34%	9.54B	-
ASAHI KASEI CORPORATION	-0.63%	8.84B	A-
SRF LIMITED	-0.90%	8.52B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes